{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:48:13Z","timestamp":1791589693422,"version":"4.3.4"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The cardiovascular disease pathogenesis is extremely complex and seriously threatens human health. Cardiomyocyte death plays a significant role in cardiovascular disease occurrence and development. In addition to the previously revealed modes of cell death (apoptosis, autophagy, and pyroptosis), ferroptosis is highly related to the development of cardiovascular diseases, including arrhythmia, atherosclerosis, and myocardial ischemia\/reperfusion. Ferroptosis is a novel cell death pathway driven by lipid peroxidation and iron overload. Lipid, amino acid, and iron metabolism regulate the ferroptosis pathway. Small molecule compounds (iron chelators, antioxidants, and ferroptosis inhibitors) and genetic programming can alleviate or prevent cardiovascular disease by inhibiting the ferroptosis pathway. Ferroptosis plays a key role in various cardiovascular disease occurrence and development, and inhibiting ferroptosis in cardiomyocytes is expected to become a feasible treatment method. In this mini-review, we systematically summarize the molecular mechanisms of ferroptosis in different cardiovascular diseases, delineate the regulatory network between ferroptosis and cardiovascular diseases, and highlight its potential therapeutic targets.<\/jats:p>","DOI":"10.3389\/fcvm.2022.1077332","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T07:35:13Z","timestamp":1671176113000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Research progress on the role of ferroptosis in cardiovascular disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Han","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Long","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease.","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of non-apoptotic cell death.","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112423","article-title":"The molecular mechanisms of ferroptosis and its role in cardiovascular disease.","volume":"145","author":"Zhang","year":"2022","journal-title":"Biomed Pharmacother."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00239","article-title":"Ferroptosis and its potential role in human diseases.","volume":"11","author":"Han","year":"2020","journal-title":"Front Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/biology10030184","article-title":"Lipid metabolism and ferroptosis.","volume":"10","author":"Lee","year":"2021","journal-title":"Biology."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00735-4","article-title":"The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease.","author":"Fang","year":"2022","journal-title":"Nat Rev Cardiol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.733229","article-title":"The role of ferroptosis in cardiovascular disease and its therapeutic significance.","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B9","first-page":"1650","article-title":"Insights into the novel function of system Xc- in regulated cell death.","volume":"25","author":"Tu","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.gendis.2020.09.005","article-title":"Ferroptosis: an emerging therapeutic opportunity for cancer.","volume":"9","author":"Wang","year":"2022","journal-title":"Genes Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2019.151058","article-title":"Mitochondria regulation in ferroptosis.","volume":"99","author":"Wang","year":"2020","journal-title":"Eur J Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00579-w","article-title":"Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases.","volume":"7","author":"Yu","year":"2021","journal-title":"Cell Death Discov."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1397-3","article-title":"Iron and leukemia: new insights for future treatments.","volume":"38","author":"Wang","year":"2019","journal-title":"J Exp Clin Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121864","article-title":"Iron overload, oxidative stress, and ferroptosis in the failing heart and liver.","volume":"10","author":"Mancardi","year":"2021","journal-title":"Antioxidants."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1360\/TB-2019-0242","article-title":"Role of iron overload and ferroptosis in heart disease (in Chinese)","volume":"64","author":"Fang","year":"2019","journal-title":"Chin Sci Bull."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.707138","article-title":"Iron in cardiovascular disease: challenges and potentials.","volume":"8","author":"Li","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease.","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5695723","article-title":"The Nrf-2\/HO-1 signaling axis: a ray of hope in cardiovascular diseases.","volume":"2020","author":"Zhang","year":"2020","journal-title":"Cardiol Res Pract."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100866","article-title":"Basics and principles of cellular and systemic iron homeostasis.","volume":"75","author":"Katsarou","year":"2020","journal-title":"Mol Aspects Med."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis.","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00267","article-title":"Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases.","volume":"14","author":"Song","year":"2020","journal-title":"Front Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/jep.13685","article-title":"Use of thromboprophylaxis guidelines and risk stratification tools in atrial fibrillation: a survey of general practitioners in Australia.","volume":"28","author":"Gebreyohannes","year":"2022","journal-title":"J Eval Clin Pract."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2687807","article-title":"Exosomes from bone marrow mesenchymal stem cells with overexpressed Nrf2 inhibit cardiac fibrosis in rats with atrial fibrillation.","volume":"2022","author":"Xu","year":"2022","journal-title":"Cardiovasc Ther."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01615","article-title":"Cellular electrophysiology of iron-overloaded cardiomyocytes.","volume":"9","author":"Siri-Angkul","year":"2018","journal-title":"Front Physiol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174622","article-title":"Ferroportin-mediated ferroptosis involved in new-onset atrial fibrillation with LPS-induced endotoxemia.","volume":"913","author":"Fang","year":"2021","journal-title":"Eur J Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.153055","article-title":"Inhibition of ferroptosis reduces susceptibility to frequent excessive alcohol consumption-induced atrial fibrillation.","volume":"465","author":"Dai","year":"2022","journal-title":"Toxicology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complications in COVID-19.","volume":"38","author":"Long","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/CIRCRESAHA.121.320518","article-title":"SARS-CoV-2 infection induces ferroptosis of sinoatrial node pacemaker cells.","volume":"130","author":"Han","year":"2022","journal-title":"Circ Res."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1587922","article-title":"Targeting ferroptosis: pathological mechanism and treatment of ischemia-reperfusion injury.","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid Med Cell Longev."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.570867","article-title":"Saponins in Chinese herbal medicine exerts protection in myocardial ischemia-reperfusion injury: possible mechanism and target analysis.","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01090-z","article-title":"ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage.","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduct Target Ther."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.672391","article-title":"LncAABR07025387.1 enhances myocardial ischemia\/reperfusion injury via miR-205\/ACSL4-mediated ferroptosis.","volume":"10","author":"Sun","year":"2022","journal-title":"Front Cell Dev Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/dna.2019.5097","article-title":"Ferroptosis is involved in diabetes myocardial ischemia\/reperfusion injury through endoplasmic reticulum stress.","volume":"39","author":"Li","year":"2020","journal-title":"DNA Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.551318","article-title":"USP22 protects against myocardial ischemia-reperfusion injury via the SIRT1-p53\/SLC7A11-dependent inhibition of ferroptosis-induced cardiomyocyte death.","volume":"11","author":"Ma","year":"2020","journal-title":"Front Physiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.710963","article-title":"The link between ferroptosis and cardiovascular diseases: a novel target for treatment.","volume":"8","author":"Hu","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2020.07.026","article-title":"Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell.","volume":"160","author":"Bai","year":"2020","journal-title":"Free Radic Biol Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2021.05.009","article-title":"Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis.","volume":"171","author":"Zhou","year":"2021","journal-title":"Free Radic Biol Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.14336\/AD.2020.0323","article-title":"Mechanism of ferroptosis: a potential target for cardiovascular diseases treatment.","volume":"12","author":"Ju","year":"2021","journal-title":"Aging Dis."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9304383","article-title":"High level of uric acid promotes atherosclerosis by targeting NRF2-mediated autophagy dysfunction and ferroptosis.","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid Med Cell Longev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.pharmthera.2009.10.002","article-title":"Anticancer drugs and cardiotoxicity: insights and perspectives in the era of targeted therapy.","volume":"125","author":"Raschi","year":"2010","journal-title":"Pharmacol Ther."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172818","article-title":"Effects of doxorubicin on the heart: from molecular mechanisms to intervention strategies.","volume":"866","author":"Prathumsap","year":"2020","journal-title":"Eur J Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy.","volume":"116","author":"Fang","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s41418-022-00990-5","article-title":"PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2\/GPX4 pathway.","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight."},{"key":"B45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pharmthera.2016.09.009","article-title":"Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: what is missing?.","volume":"168","author":"Magdy","year":"2016","journal-title":"Pharmacol Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","article-title":"Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1.","volume":"81","author":"Yan","year":"2021","journal-title":"Mol Cell."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2513263","article-title":"Analysis and validation of differentially expressed ferroptosis-related genes in regorafenib-induced cardiotoxicity.","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid Med Cell Longev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/21655979.2021.2004980","article-title":"Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K\/AKT signaling pathway.","volume":"13","author":"Sun","year":"2022","journal-title":"Bioengineered."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.656093","article-title":"circSnx12 Is involved in ferroptosis during heart failure by targeting miR-224-5p.","volume":"8","author":"Zheng","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217889","article-title":"The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection.","volume":"21","author":"Ravingerov\u00e1","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182842","article-title":"Ferroptosis: the potential target in heart failure with preserved ejection fraction.","volume":"11","author":"Li","year":"2022","journal-title":"Cells."},{"key":"B52","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis.","volume":"127","author":"Fang","year":"2020","journal-title":"Circ Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbrc.2018.02.061","article-title":"Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis.","volume":"497","author":"Liu","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1111\/jcmm.15067","article-title":"LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR-34a\/DKK1\/Wnt-beta-catenin signalling.","volume":"24","author":"Fang","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","article-title":"Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling.","volume":"181","author":"Zhang","year":"2022","journal-title":"Free Radic Biol Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1080\/10641963.2020.1783545","article-title":"Study on ferroptosis pathway that operates in hypertensive brain damage.","volume":"42","author":"Yang","year":"2020","journal-title":"Clin Exp Hypertens."},{"key":"B57","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10557-021-07220-z","article-title":"SLC7A11\/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis.","volume":"36","author":"Zhang","year":"2022","journal-title":"Cardiovasc Drugs Ther."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.737971","article-title":"Targeting ferroptosis to treat cardiovascular diseases: a new continent to be explored.","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2020.10.010","article-title":"HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes.","volume":"150","author":"Wang","year":"2021","journal-title":"J Mol Cell Cardiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","article-title":"Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways.","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-3789","article-title":"Activation of AMPK\/p38\/Nrf2 is involved in resveratrol alleviating myocardial ischemia-reperfusion injury in diabetic rats as an endogenous antioxidant stress feedback.","volume":"10","author":"Xu","year":"2022","journal-title":"Ann Transl Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2020.08.009","article-title":"Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury.","volume":"160","author":"Li","year":"2020","journal-title":"Free Radic Biol Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"9367","DOI":"10.1080\/21655979.2021.2001913","article-title":"Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction.","volume":"12","author":"Xiao","year":"2021","journal-title":"Bioengineered."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1172\/JCI126428","article-title":"Ferroptotic cell death and TLR4\/Trif signaling initiate neutrophil recruitment after heart transplantation.","volume":"129","author":"Li","year":"2019","journal-title":"J Clin Investig."},{"key":"B65","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bbrc.2019.10.006","article-title":"Ferroptosis inhibitor, liproxstatin-1, protects the myocardium against ischemia\/reperfusion injury by decreasing VDAC1 levels and rescuing GPX4 levels.","volume":"520","author":"Feng","year":"2019","journal-title":"Biochem Biophys Res Commun."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.685434","article-title":"Protective effects of dexazoxane on rat ferroptosis in doxorubicin-induced cardiomyopathy through regulating HMGB1.","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10101624","article-title":"Histochrome attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis-induced cardiomyocyte death.","volume":"10","author":"Hwang","year":"2021","journal-title":"Antioxidants."},{"key":"B68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","article-title":"Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis.","volume":"27","author":"Chen","year":"2020","journal-title":"Cell Death Differ."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118356","article-title":"Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4.","volume":"259","author":"Wang","year":"2020","journal-title":"Life Sci."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3159717","article-title":"Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway.","volume":"2022","author":"Wei","year":"2022","journal-title":"Cardiovasc Ther."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8438528","article-title":"Glycyrrhizin attenuates hypoxic-ischemic brain damage by inhibiting ferroptosis and neuroinflammation in neonatal rats via the HMGB1\/GPX4 pathway.","volume":"2022","author":"Zhu","year":"2022","journal-title":"Oxid Med Cell Longev."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.628988","article-title":"Baicalin prevents myocardial ischemia\/reperfusion injury through inhibiting ACSL4 mediated ferroptosis.","volume":"12","author":"Fan","year":"2021","journal-title":"Front Pharmacol."},{"key":"B73","first-page":"14497","article-title":"Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2\/HO-1 signaling pathway.","volume":"8","author":"Zeng","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejphar.2018.08.024","article-title":"Betulinic acid alleviates myocardial hypoxia\/reoxygenation injury via inducing Nrf2\/HO-1 and inhibiting p38 and JNK pathways.","volume":"838","author":"Wang","year":"2018","journal-title":"Eur J Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145968","article-title":"Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis.","volume":"808","author":"Li","year":"2022","journal-title":"Gene."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8880141","article-title":"The protective effect of cyanidin-3-glucoside on myocardial ischemia-reperfusion injury through ferroptosis.","volume":"2021","author":"Shan","year":"2021","journal-title":"Oxid Med Cell Longev."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174981","article-title":"Reduction of iron toxicity in the heart of iron-overloaded mice with natural compounds.","volume":"924","author":"Alikhani","year":"2022","journal-title":"Eur J Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102185","article-title":"Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPKalpha2 and activating adaptive autophagy.","volume":"48","author":"He","year":"2021","journal-title":"Redox Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.18632\/aging.204033","article-title":"Puerarin protects against sepsis-induced myocardial injury through AMPK-mediated ferroptosis signaling.","volume":"14","author":"Zhou","year":"2022","journal-title":"Aging."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154086","article-title":"Shensong Yangxin attenuates metabolic syndrome-induced atrial fibrillation via inhibition of ferroportin-mediated intracellular iron overload.","volume":"101","author":"Yang","year":"2022","journal-title":"Phytomedicine."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201667","article-title":"Tanshinone functions as a coenzyme that confers gain of function of NQO1 to suppress ferroptosis.","volume":"6","author":"Wang","year":"2022","journal-title":"Life Sci Alliance."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105466","article-title":"Ferroptosis and its emerging roles in cardiovascular diseases.","volume":"166","author":"Li","year":"2021","journal-title":"Pharmacol Res."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1077332\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:44:42Z","timestamp":1671727482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1077332\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":82,"alternative-id":["10.3389\/fcvm.2022.1077332"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1077332","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"article-number":"1077332"}}